Advanced Enzyme Technologies’ covid fatigue treatment passes clinical trials

13 Sep 2021 Evaluate

Advanced  Enzyme  Technologies’ systemic  enzyme  and  probiotic  supplements - ImmunoSEB  and  ProbioSEB  CSC3  have  passed  the  promising  stages  of  randomized  controlled clinical trials in terms of efficacy to resolve post?COVID fatigue symptoms.

With  an  aim  to  evaluate  the  efficacy  and  safety  of  the  health  supplements  ImmunoSEB  (systemic enzyme  complex)  and  ProbioSEB  CSC3  (probiotic  complex)  in  patients  suffering  from  COVID?19 induced  fatigue,  a  randomized,  multi?centric,  double  blind  and  placebo?controlled  trial  was  conducted in 200 patients suffering from post?COVID fatigue symptoms. The test arm (100 patients) received the oral supplements for 14-days and the control arm (100 patients) received placebo.

Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.

Advanced Enzyme Share Price

301.15 1.25 (0.42%)
31-Dec-2025 12:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.70
Dr. Reddys Lab 1269.00
Cipla 1501.20
Zydus Lifesciences 913.50
Lupin 2104.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×